141 related articles for article (PubMed ID: 1349506)
1. Parkinsonism associated with calcium channel blockers: a prospective follow-up study.
García-Ruiz PJ; García de Yébenes J; Jiménez-Jiménez FJ; Vázquez A; García Urra D; Morales B
Clin Neuropharmacol; 1992 Feb; 15(1):19-26. PubMed ID: 1349506
[TBL] [Abstract][Full Text] [Related]
2. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
4. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
Calzetti S; Negrotti A
J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
[TBL] [Abstract][Full Text] [Related]
5. Flunarizine-induced parkinsonism: clinical report.
Moretti A; Lucantoni C
Ital J Neurol Sci; 1988 Jun; 9(3):295-7. PubMed ID: 3403223
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
[No Abstract] [Full Text] [Related]
8. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
9. Drug induced parkinsonism: a common cause of parkinsonism in older people.
Thanvi B; Treadwell S
Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced movement disorders.
Jiménez-Jiménez FJ; García-Ruiz PJ; Molina JA
Drug Saf; 1997 Mar; 16(3):180-204. PubMed ID: 9098656
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G
Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced parkinson syndromes].
Nguyen N; Pradel V; Micallef J; Montastruc JL; Blin O
Therapie; 2004; 59(1):105-12. PubMed ID: 15199676
[TBL] [Abstract][Full Text] [Related]
14. Cinnarizine-induced parkinsonism: ten years later.
Negrotti A; Calzetti S
Mov Disord; 1999 May; 14(3):534-5. PubMed ID: 10348490
[No Abstract] [Full Text] [Related]
15. Drug-induced parkinsonism in the aged. Recognition and prevention.
Gershanik OS
Drugs Aging; 1994 Aug; 5(2):127-32. PubMed ID: 7981484
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
Opie LH
Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
[TBL] [Abstract][Full Text] [Related]
17. [Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].
Martí Massó JF
Neurologia; 1986; 1(2):55-7. PubMed ID: 3079110
[No Abstract] [Full Text] [Related]
18. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
Silver M; Factor SA
Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced parkinsonism].
Levin OS; Shindriaeva NN; Anikina MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):76-81. PubMed ID: 23096050
[No Abstract] [Full Text] [Related]
20. [Akathisia, parkinsonism and depression induced by cinnarizine: a case report].
Stucchi-Portocarrero S; Vega-Dienstmaier JM; Saavedra JE; Sagástegui A
Rev Neurol; 1999 May 1-15; 28(9):876-8. PubMed ID: 10390751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
